ECHO Webinar: Maximizing the Benefits of Cell Therapy by Developing T Cell Products from Renewable Induced Pluripotent Stem Cells

Join the ECHO webinar featuring Dr. Shreya Shukla (Co-Founder & Director of Research, Notch Therapeutics)!
Dr. Shukla’s presentation entitled, “Maximizing the Benefits of Cell Therapy by Developing T Cell Products from Renewable Induced Pluripotent Stem Cells”, will feature an overview of Notch Therapeutics, its technologies and the story behind its success.
Notch Therapeutics is developing a pipeline of cellular immunotherapies originating from pluripotent stem cells that are specifically engineered to address the underlying biology of complex disease systems.
Date
Tuesday, February 22, 2022
11:00 am – 12:00 pm EST
11:00 am – 12:00 pm EST
Where
Virtual
allTags
No allTags saved to the post yet …